Page last updated: 2024-11-07

carbachol and Adverse Drug Event

carbachol has been researched along with Adverse Drug Event in 3 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Z1
Shi, Q1
Ding, D1
Kelly, R1
Fang, H1
Tong, W1
Uno, T1
Kobayashi, F1
Ogata, A1
Konomi, T1
Drance, SM1

Reviews

1 review available for carbachol and Adverse Drug Event

ArticleYear
[Pharmacological and clinical profile of imidafenacin developed as a new therapeutic agent for overactive bladder].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2008, Volume: 131, Issue:5

    Topics: Acetylcholine; Animals; Carbachol; Clinical Trials as Topic; Drug-Related Side Effects and Adverse R

2008

Other Studies

2 other studies available for carbachol and Adverse Drug Event

ArticleYear
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da

2011
Medical management of glaucoma.
    International ophthalmology clinics, 1967,Spring, Volume: 7, Issue:1

    Topics: Acute Disease; Carbachol; Carbonic Anhydrase Inhibitors; Child; Cholinesterase Inhibitors; Chronic D

1967